GURU.Markets stock price, segment price, and overall market index valuation
The company's share price AtriCure Inc.
AtriCure is a medical device company and a leader in the treatment of atrial fibrillation (AF). Its stock price reflects the growing adoption of its surgical procedures, which are becoming the gold standard in cardiac surgery.
Share prices of companies in the market segment - Medical instruments
AtriCure is a leader in the production of medical devices for the surgical treatment of atrial fibrillation. Its business consists of this single segment. We classify it as part of the Medical Instruments sector, and the graph below reflects the dynamics of the entire industry, which is dependent on the number of cardiac surgeries.
Broad Market Index - GURU.Markets
AtriCure is a medical device company specializing in the development of surgical devices for the treatment of atrial fibrillation and other arrhythmias. It is a component of the GURU.Markets index. The chart below represents the market. See how AtriCure shares compare to the cardiac surgery sector.
Change in the price of a company, segment, and market as a whole per day
ATRC - Daily change in the company's share price AtriCure Inc.
AtriCure, a manufacturer of medical equipment for treating arrhythmia, has volatility measured by change_co. It reflects sensitivity to clinical trial results and regulatory decisions. This metric is important for formulas on System.GURU.Markets for analyzing innovations in the medical technology sector.
Daily change in the price of a set of shares in a market segment - Medical instruments
AtriCure, Inc. is a company specializing in the treatment of atrial fibrillation. This chart highlights the high volatility of the MedTech sector. Comparing it to ATRC's performance helps assess how sensitive its innovative, yet niche, products are to competition and tariffs.
Daily change in the price of a broad market stock, index - GURU.Markets
AtriCure is a manufacturer of innovative devices for the surgical treatment of atrial fibrillation. The medical technology market is growing rapidly, but it is also highly competitive. The chart below shows the volatility in this sector, helping to assess how AtriCure shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization AtriCure Inc.
AtriCure is a manufacturer of innovative medical devices for the treatment of cardiovascular diseases. Its year-over-year performance reflects rapid growth and the adoption of its technologies in clinical practice. The chart below tells the story of this medical technology leader.
Annual dynamics of market capitalization of the market segment - Medical instruments
AtriCure, Inc. is a leader in the development of devices for the surgical treatment of atrial fibrillation. Its innovative products are changing approaches to cardiac surgery. The chart shows how its dominant position in this important medical niche and the growing adoption of its technologies are driving its accelerated growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
AtriCure, a manufacturer of equipment for treating atrial fibrillation, is a growth story in medicine. Its stock price is driven not by economics, but by the speed of technology adoption by surgeons. The chart illustrates how a breakthrough technology can gain market share in a conservative but vast market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization AtriCure Inc.
The growth of AtriCure, a manufacturer of medical devices for the treatment of atrial fibrillation, depends on the volume of procedures. The monthly fluctuations on the graph reflect the growth in the number of surgeries using its products, a key indicator of the adoption of its technology in cardiac surgery.
Monthly dynamics of market capitalization of the market segment - Medical instruments
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation (AF), a common heart rhythm disorder. The graph below illustrates the overall trend in the medical device sector, where innovations that improve surgical outcomes are in high demand.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
AtriCure is a medical device company developing devices for treating arrhythmia. Its stock price is driven not by market sentiment, but by internal events: clinical trial results, regulatory approvals, and the pace of hospital adoption of its technologies. It's a bet on medical innovation.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization AtriCure Inc.
AtriCure, a company specializing in the treatment of atrial fibrillation, shares reflect progress in cardiac surgery on a weekly basis. Price movements reflect the adoption of their technologies by surgeons, clinical trial results, and the growing number of cardiac surgeries using their equipment.
Weekly dynamics of market capitalization of the market segment - Medical instruments
The cardiac surgery medical instrument sector reflects innovations in this field on a weekly basis. The introduction of new treatments for arrhythmia and other heart conditions impacts all manufacturers. This chart illustrates this overall medical progress, which can be used to assess AtriCure's position.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
AtriCure develops devices for the surgical treatment of atrial fibrillation. Demand for its products is driven by serious medical indications. The chart below shows how AtriCure shares are a "defensive" medical stock, vulnerable to market fluctuations due to the constant demand for its procedures.
Market capitalization of the company, segment and market as a whole
ATRC - Market capitalization of the company AtriCure Inc.
AtriCure's market capitalization chart tells the story of a leader in the development of surgical solutions for the treatment of atrial fibrillation (AF). Its robust growth reflects the growing recognition of its technologies in the medical community. Its growth reflects the market's assessment of its ability to expand its indications and become the standard of care for this common condition.
ATRC - Share of the company's market capitalization AtriCure Inc. within the market segment - Medical instruments
AtriCure is a leader in the development and production of devices for the surgical treatment of atrial fibrillation (AF). Its dominant share in this highly specialized market reflects the clinical superiority of its products. The chart shows the weight of this medical company solving a serious heart problem.
Market capitalization of the market segment - Medical instruments
AtriCure is a leader in the development and production of devices for the surgical treatment of atrial fibrillation. The chart below shows the market capitalization of the medical device sector. Its growth reflects the growing prevalence of cardiac arrhythmias and the need for effective treatments, where AtriCure holds a dominant position.
Market capitalization of all companies included in a broad market index - GURU.Markets
AtriCure produces medical devices for the surgical treatment of atrial fibrillation (AF). Its market capitalization reflects the demand for solutions to one of the most common heart conditions. The chart below shows the weight of this important segment of cardiac surgery.
Book value capitalization of the company, segment and market as a whole
ATRC - Book value capitalization of the company AtriCure Inc.
AtriCure's book value is derived from its manufacturing facilities for surgical instruments for the treatment of atrial fibrillation, as well as its patent portfolio. This is tangible, knowledge-intensive capital that saves patients from stroke. How has this innovative medical asset grown? The chart below clearly illustrates its growth dynamics.
ATRC - Share of the company's book capitalization AtriCure Inc. within the market segment - Medical instruments
AtriCure develops and manufactures innovative equipment for the treatment of cardiac arrhythmia in its own sterile facilities. The chart shows the share of these unique tangible assets in the sector, reflecting the physical foundation upon which life-saving technologies are created.
Market segment balance sheet capitalization - Medical instruments
The production of complex medical equipment, as the BCap_Seg chart shows, is capital-intensive. AtriCure, which specializes in the treatment of atrial fibrillation, confirms this. Its innovative products require significant investment in high-precision manufacturing and R&D, creating a high barrier to entry.
Book value of all companies included in the broad market index - GURU.Markets
AtriCure's book value is derived from its high-tech manufacturing facilities and laboratories where surgical instruments for treating arrhythmia are created. It reflects the physical capital invested in creating the tangible devices that enable surgeons to literally repair human hearts.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - AtriCure Inc.
AtriCure develops medical devices for the treatment of atrial fibrillation. The company's book value does not reflect the value of its patents and clinical research. The MvsBCap chart demonstrates the market's high valuation of its intellectual property and growth potential. The company's performance will depend on the success of its new products and regulatory approvals.
Market to book capitalization ratio in a market segment - Medical instruments
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. The company's value is determined by its patents, clinical data, and regulatory approvals. This metric demonstrates the high premium the market pays for its innovative technologies and leadership in its medical niche.
Market to book capitalization ratio for the market as a whole
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. The company's value lies in its innovative technologies, patents, and clinical data, not its manufacturing facilities. This chart shows how the market values intellectual property in the MedTech sector, which promises to save lives and generate high profits.
Debts of the company, segment and market as a whole
ATRC - Company debts AtriCure Inc.
AtriCure, a developer of medical devices for the treatment of atrial fibrillation, uses debt financing to conduct costly clinical trials and bring new products to market. The journey from concept to FDA-approved device requires significant investment. This chart shows how the company is investing in the future of cardiac surgery by managing its finances.
Market segment debts - Medical instruments
AtriCure develops and manufactures innovative medical devices for the treatment of atrial fibrillation. In the medtech industry, where R&D and clinical trials require enormous expenditures, debt is an important element of its strategy. This chart shows how AtriCure finances its product development and commercialization compared to its competitors.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio AtriCure Inc.
AtriCure develops and markets medical devices for the treatment of atrial fibrillation. This chart demonstrates the company's reliance on debt capital. In the MedTech sector, where R&D and clinical trials require enormous expenditures, capital structure is critical. High debt can pose a risk if a new product fails to receive regulatory approval in a timely manner.
Market segment debt to market segment book capitalization - Medical instruments
AtriCure develops and markets medical devices for the treatment of arrhythmia, which requires significant investment in R&D and clinical trials. This chart shows how much debt capital the entire medical device industry is raising to fund innovation. This helps assess how aggressively the company is investing in the future compared to its competitors.
Debt to book value of all companies in the market
AtriCure is a medical device company driven by innovation. This metric reflects the average leverage level across the market. This helps understand how the company's capital-intensive strategy and industry compare to the overall economic environment and capital availability.
P/E of the company, segment and market as a whole
P/E - AtriCure Inc.
This chart of AtriCure, a developer of medical devices for the treatment of atrial fibrillation, shows how the market values its innovative products. High multiples may indicate investors' confidence in the widespread adoption of the company's technologies in cardiac surgery and its potential to capture a significant market share.
P/E of the market segment - Medical instruments
This chart shows the average P/E ratio for the medical instruments sector, where AtriCure competes. This high-tech industry is valued by the market with a premium for innovation. This metric helps us understand how AtriCure's growth expectations and product adoption align with overall trends in the cardiac surgery sector.
P/E of the market as a whole
AtriCure develops and manufactures innovative devices for the surgical treatment of atrial fibrillation. The company is a leader in its medical niche. This market temperature chart helps us understand whether AtriCure is valued for its unique technology and growth potential, or whether its valuation is driven by the overall sentiment in the biotech sector and the market as a whole.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company AtriCure Inc.
AtriCure develops and markets medical devices for the surgical treatment of atrial fibrillation. The chart shows Wall Street's expectations for future profits, which depend on surgical volume, new product approvals, and increased use of the company's technology by surgeons. This represents a glimpse into the growth potential of this highly specialized niche.
%20P%2FE%20AtriCure%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-AtriCure-Inc.&v=1772584751628 "Chart of the company's future (projected) P/E AtriCure Inc.")
Future (projected) P/E of the market segment - Medical instruments
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation. The company is a leader in its narrow but important niche. This chart compares AtriCure's future profitability expectations with those of its sector. It helps understand whether the market is pricing in future advances in arrhythmia treatment.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medical-instruments&v=1772584751703 "Future (projected) P/E graph of the market segment - Medical instruments")
Future (projected) P/E of the market as a whole
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation and other heart conditions. It is an innovative company in the MedTech sector. This overall risk appetite chart helps understand how willing investors are to invest in companies with long product development cycles and large potential markets.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772584751804 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit AtriCure Inc.
AtriCure, Inc. specializes in the development and sale of medical devices for the surgical treatment of atrial fibrillation (AF). The company's revenue is directly dependent on the number of surgeries performed using its innovative products. This chart shows financial results reflecting the adoption of its technologies in cardiac surgery.
Profit of companies in the market segment - Medical instruments
AtriCure, Inc. develops and manufactures medical devices for the surgical treatment of atrial fibrillation (AF). The company is a leader in its narrow but important niche. This chart reflects overall profitability in the medical devices sector, where innovation, clinical research, and regulatory approval are key to commercial success.
Overall market profit
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. Demand for the company's products is driven by medical needs and innovations, rather than by general economic cycles, as illustrated by this graph. This allows AtriCure to demonstrate growth based on the clinical effectiveness of its solutions, regardless of market conditions.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company AtriCure Inc.
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation (AF). The company's future profitability depends on the number of surgeries performed and the adoption of its technologies in clinical practice. This chart reflects analyst expectations for the growth of the arrhythmia treatment market and AtriCure's market share.
%20profit%20of%20the%20company%20AtriCure%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-AtriCure-Inc.&v=1772584752100 "Graph of future (projected) profit of the company AtriCure Inc.")
Future (predicted) profit of companies in the market segment - Medical instruments
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation and other cardiac conditions. Demand for the company's products is growing alongside the spread of cardiovascular pathologies. This chart shows projected revenue growth for the entire medical devices sector, providing context for assessing AtriCure's potential.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medical-instruments&v=1772584752134 "Graph of future (predicted) profits of companies in a market segment - Medical instruments")
Future (predicted) profit of the market as a whole
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation. Demand for the company's products depends on the number of surgeries performed. This economic outlook is important, as a stable economy ensures reliable funding for healthcare systems and access to elective procedures for patients.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772584752148 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - AtriCure Inc.
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. For a medtech company, revenue growth signifies successful adoption of its technologies by surgeons. This chart shows the premium investors are willing to pay for innovation and life-saving potential. The high multiple reflects expectations for continued sales growth.
P/S market segment - Medical instruments
AtriCure develops and markets medical devices for the surgical treatment of atrial fibrillation (AF) and other cardiovascular conditions. The company's innovative products are changing the standards of cardiac surgery. This chart shows the average revenue estimate for the medical device sector, reflecting how the market values AtriCure's advanced technologies.
P/S of the market as a whole
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation (AF). The company is a leader in its niche. This chart, showing the average market revenue estimate, helps understand the premium investors are willing to pay for innovative medical technologies and market leadership in this niche.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company AtriCure Inc.
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation (AF). For a company in the medical technology sector, future revenue estimates are crucial. They reflect investor expectations for the clinical adoption of its technologies and the growth in the number of procedures, which directly impacts future device sales.
%20P%2FS%20AtriCure%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-AtriCure-Inc.&v=1772584752307 "The graph of the company's future (projected) P/S AtriCure Inc.")
Future (projected) P/S of the market segment - Medical instruments
AtriCure develops innovative devices for the surgical treatment of atrial fibrillation, a serious heart rhythm disorder. This chart compares the company's estimated future revenue with other medical device manufacturers. It shows how investors view its technological leadership and growth potential as its solutions are implemented in clinical practice.
%20P%2FS%20market%20segment%20graph%20-%20Medical%20instruments&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medical-instruments&v=1772584752360 "Future (projected) P/S market segment graph - Medical instruments")
Future (projected) P/S of the market as a whole
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. Demand for its products is driven by medical needs, not economic conditions. In the overall revenue growth picture illustrated by the chart, AtriCure represents the innovative healthcare sector.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772584752390 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales AtriCure Inc.
This chart shows the revenue of AtriCure, a company specializing in the development of devices for the surgical treatment of atrial fibrillation (AF). Revenue is directly dependent on sales of its innovative medical instruments to hospitals. This growth reflects the adoption of its technologies in cardiac surgery worldwide.
Sales of companies in the market segment - Medical instruments
AtriCure develops innovative devices for the surgical treatment of atrial fibrillation (AF). The sales breakdown in this chart shows the proportion of revenue coming from open surgeries and the proportion coming from less invasive procedures. This reflects trends in cardiac surgery and the company's success in implementing new technologies.
Overall market sales
AtriCure develops and manufactures innovative medical devices for the treatment of atrial fibrillation. The company's growth is driven by the introduction of new surgical technologies and an aging population. This chart illustrates how specialized medical companies solving specific health problems are developing against the backdrop of general economic trends affecting hospital budgets.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company AtriCure Inc.
AtriCure develops and manufactures innovative medical devices for the surgical treatment of atrial fibrillation and other cardiac conditions. The company's future revenue depends on the clinical adoption of its technologies and the volume of surgeries performed. The chart illustrates analysts' forecasts for demand for AtriCure products from cardiac surgeons and hospitals.
%20sales%20of%20the%20company%20AtriCure%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-AtriCure-Inc.&v=1772584752592 "Schedule of future (projected) sales of the company AtriCure Inc.")
Future (projected) sales of companies in the market segment - Medical instruments
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation. This chart shows the overall sales forecast for the cardiac surgical instruments market. Is the number of surgeries expected to increase due to new technologies and an aging population? This allows us to assess the potential of the entire medical segment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medical-instruments&v=1772584752648 "Schedule of future (projected) sales of companies in the market segment - Medical instruments")
Future (projected) sales of the market as a whole
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation. Demand for its products depends not on overall consumer spending, but on the number of cardiac surgeries performed and the introduction of new technologies in medicine. This metric is secondary to healthcare system factors for the company.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772584752840 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality AtriCure Inc.
AtriCure develops and manufactures medical devices for the surgical treatment of atrial fibrillation. This chart illustrates the profitability of developing innovative cardiac surgery solutions. The company's profitability is directly dependent on the successful implementation of its technologies in clinical practice and the ability to maintain a high price for its patented products.
Market segment marginality - Medical instruments
AtriCure, Inc. develops and manufactures medical devices for the surgical treatment of atrial fibrillation (AF). The company is a leader in its highly specialized niche. This metric demonstrates how innovative products that address a serious medical problem and strong relationships with surgeons enable the company to maintain high profitability.
Market marginality as a whole
AtriCure, Inc. develops innovative devices for the treatment of atrial fibrillation, and its growth depends on the implementation of new technologies in hospitals. This overall profitability chart shows the financial health of the healthcare system. High profitability makes clinics more willing to invest in advanced equipment, which accelerates AtriCure's decision-making process.
Employees in the company, segment and market as a whole
Number of employees in the company AtriCure Inc.
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. Its team consists of highly qualified engineers, clinicians, and sales specialists. This chart shows how the company invests in research, development, and promotion of its innovative surgical solutions among cardiac surgeons worldwide.
Share of the company's employees AtriCure Inc. within the market segment - Medical instruments
AtriCure develops and manufactures innovative medical devices for the treatment of atrial fibrillation. This is a high-tech industry where development engineers, clinical research specialists, and manufacturing personnel play key roles. This chart shows the company's market share among medical device manufacturers, reflecting its focus on a narrow niche and its talent pool.
Number of employees in the market segment - Medical instruments
AtriCure develops and manufactures medical instruments for the surgical treatment of atrial fibrillation and other cardiac conditions. This chart shows employment in the medical instrument manufacturing sector. The growing number of specialists in this field reflects innovation and the expanding application of new treatment methods, which underpin AtriCure's growth.
Number of employees in the market as a whole
AtriCure develops and manufactures innovative medical devices for the treatment of atrial fibrillation. The growth of its staff, comprised of highly qualified engineers and clinicians, reflects advances in cardiac surgery. Compared to the overall employment shown in this chart, AtriCure's hiring demonstrates the advancement of science-based medicine.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company AtriCure Inc. (ATRC)
AtriCure develops devices for the treatment of atrial fibrillation. This chart shows how highly the market values their medical innovations. The company's value is derived from patents and clinical data. The high market capitalization per employee reflects their leadership in their niche and the high margins of their unique products.
%20of%20the%20company%20AtriCure%20Inc.%20(ATRC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-AtriCure-Inc.-ATRC&v=1772584753151 "Chart of market capitalization per employee (in thousands of dollars) of the company AtriCure Inc. (ATRC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
AtriCure (ATRC) is a medical device company specializing in solutions for the treatment of atrial fibrillation (AF) during cardiac surgery. This chart shows the industry average market capitalization per employee. It helps understand how the market values their niche, yet critical, technology and their relationship with cardiac surgeons.
%20by%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medical-instruments&v=1772584753184 "Market capitalization per employee (in thousands of dollars) by market segment - Medical instruments")
Market capitalization per employee (in thousands of dollars) for the overall market
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. In the MedTech sector, value is driven by innovation and patents. The graph demonstrates a high market valuation per employee, driven by the uniqueness of its technology, high product margins, and significant investment in research and development.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772584753187 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company AtriCure Inc. (ATRC)
AtriCure develops and markets innovative surgical instruments, particularly for the treatment of atrial fibrillation. This is a high-tech medical sector. This metric reflects how investments in R&D and clinical trials are converted into sales of high-margin single-use devices. Efficiency here is the profit per surgeon.
%20Chart%20AtriCure%20Inc.%20(ATRC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-AtriCure-Inc.-ATRC&v=1772584753201 "Company Profit Per Employee (in thousands of dollars) Chart AtriCure Inc. (ATRC)")
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
AtriCure (ATRC) is a medtech company (treating cardiac arrhythmia). This chart shows the benchmark for "Medical Instruments." The average profit per employee in this sector is high. It's an "R&D-driven business." The benchmark reflects the high margins of patented, life-saving B2B devices, which recoup enormous R&D costs.
%20in%20the%20market%20segment%20-%20Medical%20instruments&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medical-instruments&v=1772584753233 "Chart of profit per employee (in thousands of dollars) in the market segment - Medical instruments")
Profit per employee (in thousands of dollars) for the market as a whole
AtriCure (ATRC) is a medical technology company specializing in the treatment of atrial fibrillation (arrhythmia) and related conditions. It is a R&D and manufacturing company specializing in critical devices. This chart shows how their patented surgical instruments are in demand among cardiac surgeons, allowing them to charge high prices, generating profit per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772584753249 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee AtriCure Inc. (ATRC)
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation. This chart shows how the company's innovations and intellectual property translate into revenue. High revenue per employee reflects the high value of their products and their strong market position, with each team member contributing to the creation of a high-value product.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-AtriCure-Inc.-ATRC&v=1772584753271 "Sales chart per company employee AtriCure Inc. (ATRC)")
Sales per employee in the market segment - Medical instruments
AtriCure develops and manufactures medical devices for the treatment of atrial fibrillation (arrhythmia). This is a highly specialized, knowledge-intensive medical technology business. The business requires expensive R&D specialists and surgical sales staff. This graph shows the average productivity in the sector. For AtriCure, this is a benchmark: how successful are their innovative products and sales team in generating revenue?
Sales per employee for the market as a whole
AtriCure develops and markets medical devices for the treatment of atrial fibrillation (AF). It's a high-tech medical business. Revenue is generated not by mass sales, but by R&D and a highly specialized sales team that trains surgeons. This chart demonstrates the effectiveness of this science-intensive approach.
Short shares by company, segment and market as a whole
Shares shorted by company AtriCure Inc. (ATRC)
AtriCure (ATRC) develops medical devices for the surgical treatment of atrial fibrillation (AF). This is a highly specialized medical market. This chart shows the number of shares borrowed for sale. Bears may be skeptical of the pace of physician adoption of the technology or bet that competing, less invasive treatments will prove more successful.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-AtriCure-Inc.-ATRC&v=1772584753506 "Short Shares Chart for the Company AtriCure Inc. (ATRC)")
Shares shorted by market segment - Medical instruments
AtriCure (ATRC) develops medical devices for the surgical treatment of atrial fibrillation (AF). It is a highly specialized MedTech company. This chart shows the overall shortfall in the medical devices sector. It highlights investor concerns about competition in the industry or a slowdown in the adoption of new technologies.
Shares shorted by the overall market
AtriCure (ATRC) produces devices for the treatment of atrial fibrillation. This Short_All chart shows systemic pessimism. When it rises due to recession fears, this fear causes patients to postpone elective cardiac surgeries and hospitals to cut budgets for expensive ATRC devices.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator AtriCure Inc. (ATRC)
AtriCure produces devices for the surgical treatment of atrial fibrillation. Its business depends on cardiac surgery volumes. A chart above 70 may reflect strong demand or the success of new products. A chart below 30 may be related to concerns about hospital budget cuts or competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-AtriCure-Inc.-ATRC&v=1772584753823 "RSI 14 indicator chart for the company's stock AtriCure Inc. (ATRC)")
RSI 14 Market Segment - Medical instruments
AtriCure (ATRC) is a medical technology company, a "guru" in the treatment of atrial fibrillation (AFib). They make surgical ablation instruments. The RSI_14_Seg for "Medical Instruments" (medtech) shows whether the sector is overbought. This helps us understand whether ATRC's growth reflects their niche in AFib or general overheating.
RSI 14 for the overall market
AtriCure (ATRC) produces equipment for the surgical treatment of arrhythmia. This chart shows that its business is "defensive." Demand for heart surgery isn't dependent on euphoria or panic—it's a matter of life and death. During moments of market panic, investors seek safe havens in companies with completely non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ATRC (AtriCure Inc.)
AtriCure is a company specializing in medical devices for the treatment of atrial fibrillation (AF), particularly during cardiac surgery. This chart reflects analyst consensus. Their target prices are based on the pace of surgeon adoption of AtriCure procedures and the expansion of indications for their technology.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ATRC-AtriCure-Inc.&v=1772584754022 "A chart showing analyst consensus forecasts for the expected stock price. ATRC (AtriCure Inc.)")
The difference between the consensus estimate and the actual stock price ATRC (AtriCure Inc.)
AtriCure is a medical device company focused on the treatment of atrial fibrillation (AFib). Their flagship products are devices for surgical ablation (cauterization) of cardiac tissue during open-heart surgery. This chart illustrates how much analysts believe they dominate this surgical niche.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ATRC-AtriCure-Inc.&v=1772584754040 "A chart showing the difference between the consensus forecast and the actual stock price. ATRC (AtriCure Inc.)")
Analyst consensus forecast for stock prices by market segment - Medical instruments
AtriCure is a medical company, a pioneer in the surgical treatment of atrial fibrillation (AF). Their devices allow surgeons to "cauterize" problematic areas of the heart. This chart shows general expectations for the medical devices sector. It reflects whether experts believe the cardiac ablation market will grow.
Analysts' consensus forecast for the overall market share price
AtriCure is a company that produces innovative medical equipment for the treatment of atrial fibrillation (arrhythmia), particularly during open-heart surgery. This chart shows general market sentiment. For AtriCure, a high-tech medtech company, it's important to understand how these expectations (hospital budgets) influence the implementation of their advanced surgical solutions. (346)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index AtriCure Inc.
AtriCure (ATRC) is a leader in a very specific niche: the surgical treatment of atrial fibrillation (AF). Their devices are used by cardiac surgeons for ablation during open-heart surgery. This chart is an adoption indicator, measuring their success in making their procedure the standard of care for this patient group.
AKIMA Market Segment Index - Medical instruments
AtriCure (ATRC) is a medtech leader in the treatment of atrial fibrillation (AFib); the company produces unique equipment (for surgical ablation) that helps surgeons restore heart rhythm. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does ATRC's niche model (Afib surgery) differentiate it from its average medtech competitor?
The AKIM Index for the overall market
AtriCure is a medtech company specializing in the surgical treatment of atrial fibrillation (AF). This chart, which reflects the market average, provides context. It helps assess how this growth story in medical technology, dependent on physician adoption, compares to overall economic trends.
